Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia ; volume:13 ; number:1 ; day:20 ; month:6 ; year:2018 ; pages:1-6 ; date:12.2018
Orphanet journal of rare diseases ; 13, Heft 1 (20.6.2018), 1-6, 12.2018
- Creator
-
Blom, Dirk J.
- Contributor
-
Cuchel, Marina
Ager, Miranda
Phillips, Helen
SpringerLink (Online service)
- DOI
-
10.1186/s13023-018-0841-3
- URN
-
urn:nbn:de:101:1-2018083022212968004225
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blom, Dirk J.
- Cuchel, Marina
- Ager, Miranda
- Phillips, Helen
- SpringerLink (Online service)
Other Objects (12)
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)